Advertisement

Urological Research

, Volume 25, Issue 1, pp 43–47 | Cite as

Neo-adjuvant GnRH therapy and radical prostatectomy: Effects on tumorous and benign tissue volumes —A morphometric study

  • S. Brandstedt
  • C. Busch
  • M. Hellström
  • B. Nordin
  • M. Häggman
Original Papers

Abstract

The effect on tumour and prostate volumes of a 3-month course of neo-adjuvant hormone therapy was studied using computerised planimetry on serially sectioned specimens obtained by radical prostatectomy. Fifty-four specimens from patients not receiving pre-treatment were compared to 38 specimens from patients given the gonadotropin-releasing hormone (GnRH) analogue triptorelin for 3 months before the operation. Glandular volume and volume of the index tumour was determined. To determine the position of the index tumour within the gland, the centre of mass of the tumour was identified and the distance to the gland margin calculated. This value (M1) represents the sum of the tumour radius and the various amounts of normal tissue. The amount of surrounding tissue could be approximated by correlating M1 to the corresponding tumour volume.

Results: The two groups differed significantly in total gland volumes, but not in tumour volumes.M1 was strongly correlated to the tumour volume in the treatment group (r = 0.'73), whereas in the control group the correlation was found to be significantly weaker (r = 0.44), indicating that there was less tissue surrounding the tumour in the pre-treated group. In a multiple regression analysis of all 92 patients, index tumour volume was found to be associated with total gland volume, DNA ploidy pattern, tumour grade but not whether or not pre-treatment was given. This study found that the volumes of the single largest tumour focus were not significantly affected by hormonal pretreatment, and that “the prostate condenses around the tumour rather than that the tumour shrinks back into the prostate”. However, the precise relationship between tumour epithelial volume and stroma with or without neo-adjuvant hormonal pre-treatment remains to be clarified.

Keywords

Prostate cancer Radical prostatectomy Neo-adjuvant treatment Morphometry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Terry WJ, Igel TC, Kidd DD (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143:1146Google Scholar
  2. 2.
    Enlund A, Pedersen KV, Boeryd B, Varenhorst E (1990) Transrectal ultrasonography compared to histological assessment for local staging of prostatic carcinoma. Acta Radiol 31:597Google Scholar
  3. 3.
    Fair WR, Aprikian A, Sogani P, Reuter V, Whitmore WF Jr (1993) The role of neoadjuvant hormonal manipulation in localized prostatic cancer. Cancer 71 (Suppl):1031Google Scholar
  4. 4.
    Ferguson JD, Franks LM (1953) The response of prostatic carcinoma to oestrogen treatment. Br J Surg 40:422–428Google Scholar
  5. 5.
    Flamm J, Fischer M, Höltl W, Pfluger H, Tomschi W (1991) Complete androgen deprivation prior to radical prostatectomy in patients with stage T3 cancer of the prostate. Eur Urol 19:192Google Scholar
  6. 6.
    Häggman M, de la Torre M, Brandstedt S, Norlen BJ, Norberg M, Busch C (1994) Pre- and postoperative DNA ploidy patterns correlated to pT-stage, histological grade and tumour volume in total prostatectomy specimens. Scand J Urol Nephrol 28:59Google Scholar
  7. 7.
    Häggman M, Hellström M, Aus G, Pedersen K, Wijkström H, Stege R, Elvin A, Tisell A, de la Torre M, Busch C, Brandstedt S (1993) Neoadjuvant GnRH-agonist treatment (triptorelin and cyproterone acetate for flare protection) and total prostatectomy. Eur Urol 24:456Google Scholar
  8. 8.
    Häggman M, Norberg M, de la Torre M, Fritjofsson Å, Busch C (1993) Characterization of localized prostatic cancer: distribution, grading and pT-staging in radical prostatectomy specimens. Scand J Urol Nephrol 27:7Google Scholar
  9. 9.
    Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA (1983) Method for analysis of cellular DNA content of paraffin-embedded material using flow cytometry. J Histochem Cytochem 31:1333Google Scholar
  10. 10.
    Hellström M, Ranefall P, Wester K, Brandstedt S, Busch C: Effect of androgen deprivation on epithelial and mesenchymal tissue components in localized prostate cancer. Br J Urol. AcceptedGoogle Scholar
  11. 11.
    Hellström M, Haggman M, Brandstedt S, de la Torre M, Pedersen K, Jarsfeldt I, Wijkström H, Busch C (1993) Histopathological changes in androgen deprived localized prostatic cancer. A study in total prostatectomy specimens. Eur Urol 24:461Google Scholar
  12. 12.
    Hellström M, Wester K, Haggman M, Brandstedt S, Busch C (1996) DNA ploidy patterns in androgen-deprived localized prostate cancer. Fur Urol 29:420–424Google Scholar
  13. 13.
    Lee F, Gray JM, McLeary RD, Meadows TR, Kumosaka GH, Borlaza GS, Staub WH, Lee F Jr, Solomon MH, MacHugh TA, Wolf RM (1985) Transrectal ultrasound in the diagnosis of prostate cancer: location, echogenicity, histopathology and staging. Prostate 7:117Google Scholar
  14. 14.
    Macfarlane MT, Abi-Aad A, Stein A, Danella J, Belldegrun A, DeKernion JB (1993) Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. J Urol 150:132Google Scholar
  15. 15.
    Malmström P-U, Vasko J, Wester K, Norlen BJ, Busch C (1989) Flow cytometric analysis of DNA content of deparaffinized nuclei in urinary bladder carcinomas. APMIS 97:811–819Google Scholar
  16. 16.
    Monfette G, Dupont A, Labrie F (1989) Temporary combination therapy with Flutamide and Tryptex as adjuvant to radical prostatectomy for the treatment of early stage prostate cancer. In: Labrie F, Lee F, Dupont A (eds) Early stage prostate cancer: diagnosis and choice of therapy. Excerpta Medica, Amsterdam, pp 41–51Google Scholar
  17. 17.
    Mostofi FK (1975) Grading of prostatic carcinoma. Cancer Chemother Rep 59:111Google Scholar
  18. 18.
    Norberg M, Haggman M, Andersson T, Busch C, Magnusson A (1993) Evaluation of localized prostate cancer -a comparative study of transrectal ultrasonography versus histopathology. Eur Radiol 3:166Google Scholar
  19. 19.
    Oesterling JE (1991) Prostate-specific antigen: a critical assessment of the most useful tumour markers for adenocarcinoma of the prostate. J Urol 145:907Google Scholar
  20. 20.
    Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC (1989) Morphometric measurement of tumour volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141:341Google Scholar
  21. 21.
    Pinault S, Tetu B, Gagnon J, Monfette G, Dupont A, Labrie F (1992) Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with Flutamide. Urology 39:254Google Scholar
  22. 22.
    Ritchie JP (1994) Management of patients with positive surgical margins following radical prostatectomy. Urol Clin N Am 21:717Google Scholar
  23. 23.
    Salo JO, Rannikko S (1994) The role of radical surgery in the treatment of prostatic cancer. Ann Med 26:147Google Scholar
  24. 24.
    Schröder F, Hermanek P, Denis L, Fair WR, Gospoddarowicz MK, Pavone-Macaluso M (1992) The TNM classification of prostate cancer. Prostate Suppl 4:129Google Scholar
  25. 25.
    Schulman CC, Sassine AM (1993) Neoadjuvant hormonal deprivation before radical prostatectomy. Clin Invest Med 16:523Google Scholar
  26. 26.
    Takayama TK, Lange PH (1994) Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol Clin North Am 21:687Google Scholar
  27. 27.
    Tunn UW, Goldschmidt AJW (1990) Effects of temporary antiandrogenic treatment prior to radical prostatectomy. In: Murphy G, Khoury S, Chatelain C, Denis L (eds) Recent advances in urological cancers — diagnosis and treatment. SCI, Jersey, p 102Google Scholar
  28. 28.
    Vallet BS (1944) Radical perineal prostatectomy subsequent to bilateral orchiectomy. Del Med J 16:18Google Scholar
  29. 29.
    Walsh PC, Leper H, Eggleston JC (1983) Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 4:473Google Scholar
  30. 30.
    Walsh PC, Partin AW, Epstein JI (1994) Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152:1831Google Scholar
  31. 31.
    Zietman AL, Shipley WU, Willett CG (1993) Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications. Cancer 71 (Suppl 3):959Google Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • S. Brandstedt
    • 1
  • C. Busch
    • 2
  • M. Hellström
    • 1
  • B. Nordin
    • 3
  • M. Häggman
    • 4
  1. 1.Department of Urology, Karolinska InstituteDanderyd HospitalDanderydSweden
  2. 2.Department of Pathology, University HospitalUppsala UniversityUppsalaSweden
  3. 3.Centre for Image AnalysisUppsala UniversityUppsalaSweden
  4. 4.Department of Urology, University HospitalUppsala UniversityUppsalaSweden

Personalised recommendations